Manhattan HIV/Hepatology Brain Bank
|ClinicalTrials.gov Identifier: NCT00300209|
Recruitment Status : Completed
First Posted : March 8, 2006
Last Update Posted : March 17, 2016
Description: The Manhattan HIV/Hepatology Brain Bank (MHBB) was established in 1998 as a resource for the AIDS research community. The MHBB was created to act as a center for the provision of pre- and post-mortem tissues and body fluids from HIV infected persons. It has recently expanded its goals to assist in the elucidation of liver disease-induced nervous system disorders.
The MHBB is dedicated to improving the understanding of HIV and Hepatitis C and thereby, improving the lives of patients living with HIV and/or Hepatitis C.
Participation is voluntary and can be stopped at any time.
Benefits: This is an observational study; no experimental procedures, devices or drugs are used. All enrolled patients undergo regular examinations by physicians, nurses, and neuropsychologists who specialize in the problems that HIV and HCV can cause.
Taking part in this study may result in the detection of brain, muscle, or spinal cord disease for which treatments may be available. Participants may receive no direct benefit from this study. However, knowledge gained from this research may, in the future, help others who suffer from HIV/AIDS and/or liver disease.
Participants agree to autopsy and organ donation upon demise by signing an Anatomical Gift Consent document.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||187 participants|
|Official Title:||Manhattan HIV/Hepatology Brain Bank|
|Study Start Date :||September 1998|
|Primary Completion Date :||June 2002|
|Study Completion Date :||June 2002|
- Viral Load blood level [ Time Frame: Baseline ]Plasma viral load level
- CD4 cell blood level [ Time Frame: Baseline ]
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00300209
|United States, New York|
|Mount Sinai School of Medicine|
|New York, New York, United States, 10029|
|Principal Investigator:||Susan Morgello, MD||Icahn School of Medicine at Mount Sinai|